[1]Mitsuro C, Kunio N, Hitoshi A, et al. Onset of ulcerative colitis in a patient with nonalcoholic fatty liver disease (NALFD): dramatic effect of plant-based diet for NAFLD. Inflamm Bowel Dis, 2019, 25(11):146-147. [2]Ghareghani P, Shanaki M, Ahmadi S, et al. Aerobic endurance training improves nonalcoholic fatty liver disease (NAFLD) features via mir-33 dependent autophagy induction in high fat diet fed mice. Obes Res Clin Pract, 2017, 12(2):80-89. [3]Han M, Saouaf R, Ayoub W, et al. Magnetic resonance imaging and transient elastography in the management of nonalcoholic fatty liver disease (NAFLD). Expert Rev Clin Pharmacol, 2017, 10(4):379-390. [4]Campo J, Durán RG, Gallego P, et al. Genetic and epigenetic regulation in nonalcoholic fatty liver disease (NAFLD). Int J Mol Sci, 2018, 19(3):911-911. [5]Lonardo A, Nascimbeni F, Maurantonio M, et al. Nonalcoholic fatty liver disease: evolving paradigms. World J Gastroenterol, 2017, 23(36):6571-6592. [6]Noureddin M, Loomba R. Role of leucine-metformin-sildenafil combination in the treatment of nonalcoholic fatty liver disease (NAFLD). Aliment Phar Ther, 2018, 48(3):378-379. [7]Chen Q, Wang TT, Li J, et al. Effects of natural products on fructose-induced nonalcoholic fatty liver disease (NAFLD). Nutrients, 2017, 9(2):96-96. [8]陈丽如, 张立平. 柴芪汤对非酒精性脂肪性肝病大鼠肝组织LXRα蛋白表达的影响. 中华中医药杂志, 2017, 8(32):125-128. [9]Yang JM, Sun Y, Wang M, et al. Regulatory effect of a Chinese herbal medicine formula on nonalcoholic fatty liver disease. World J Gastroenterol, 2019, 25(34):5105-5119. [10] 中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南(2010年修订版). 中华肝脏病杂志, 2010, 18(3):167-170. [11] 郑筱萸. 中药新药临床研究指导原则. 北京:中国医药科技出版社, 2002:227-227. [12] 娜日苏, 包纳日斯. 光明盐四味汤散对非酒精性脂肪性肝病模型小鼠血脂及肝功能的影响. 中华中医药杂志, 2017, 32(8):3782-3784. [13] 李自辉, 张娜, 王宇,等. 基于16S rRNA技术与代谢组学探究茵陈蒿汤治疗非酒精性脂肪性肝病的作用机制. 中华中医药杂志, 2019, 34(5):74-79. [14] Machado MV, Policarpo S, Coutinho J, et al. What is the role of the new index relative fat mass (RFM) in the assessment of nonalcoholic fatty liver disease (NAFLD)? Obes Surg, 2020, 30(4):1-9. [15] Mohamed RZ, Jalaludin MY, Zaini AA . Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity. J Pediatrc Endocr Met, 2020, 33(2):247-253. [16] Okiyama W, Tanaka N, Nakajima T, et al. Polyene phosphatidylcholine prevents alcoholic liver disease in pparα-null mice through attenuation of increases in oxidative stress. J Hepatol, 2009, 50(6):1236-1246. [17] Pan W, Hao WT, Xu HW, et al. Polyene phosphatidylcholine inhibited the inflammatory response in LPS-stimulated macrophages and ameliorated the adjuvant-induced rat arthritis. Ame J Transl Res, 2017, 9(9):4206-4261. [18] Ahmed AM, Ghany MA, Hakeem GA, et al. Assessment of vitamin d status in a group of Egyptian children with non-alcoholic fatty liver disease (multicenter study). Nutr Metab, 2016, 13(1):53-53. [19] Alonso AO, Stephens C, Lucena Ml, et al. Case characterization, clinical features and risk factors in drug-induced liver injury. Int J Mol Sci, 2016, 17(5):714-714. [20] Duan RL, Sun X, Liu J, et al. Mixed micelles loaded with silybin-polyene phosphatidylcholine complex improve drug solubility. Acta pharmacol Sin,2011,32(1):108-15. |